Neuronal nitric oxide synthase is up-regulated by angiotensin II and attenuates NADPH oxidase activity and facilitates relaxation in murine left ventricular myocytes

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 6, 2012, Pages 1274-1281

  Jin, Chun Zi ^a   Jang, Ji Hyun ^a   Wang, Yue ^a   Kim, Jae Gon ^b   Bae, Young Min ^b   Shi, Jun ^c   Che, Cheng Ri ^c   Kim, Sung Joon ^a   Zhang, Yin Hua ^a  

^a Seoul National University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

Angiotensin II; NADPH oxidase; NNOS; Reactive oxygen species; Relaxation

Indexed keywords

ANGIOTENSIN II; CALCIUM ION; CYCLIC GMP; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; PHOSPHOLAMBAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S METHYLTHIOCITRULLINE; SERINE;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; IMMUNOBLOTTING; IN VIVO STUDY; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMERE;

ANGIOTENSIN II; ANIMALS; DIASTOLE; HEART VENTRICLES; MICE; MYOCYTES, CARDIAC; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

MURINAE;

EID: 84860542485     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.03.013     Document Type: Article

References (42)

1. Varagic J., Frohlich E.D. Local cardiac renin-angiotensin system: hypertension and cardiac failure. J Mol Cell Cardiol 2002, 34(11):1435-1442.
2. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic Biol Med 2009, 47:1239-1253.
3. Nediani C., Raimondi L., Borchi E., Cerbai E. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal 2011, 14:289-331.
4. Nabeebaccus A., Zhang M., Shah A.M. NADPH oxidases and cardiac remodelling. Heart Fail Rev 2011, 16:5-12.
5. Paulus W.J., Vantrimpont P.J., Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 1994, 89:2070-2078.
6. Shah A.M., MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 2000, 86:49-86.
7. Sears C.E., Bryant S.M., Ashley E.A., Lygate C.A., Rakovic S., Wallis H.L., et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 2003, 92:52e-59e.
8. Zhang Y.H., Zhang M.H., Sears C.E., Emanuel K., Redwood C., El-Armouche A., et al. Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 2008, 102:242-249.
9. Damy T., Ratajczak P., Shah A.M., Camors E., Marty I., Hasenfuss G., et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 2004, 363:1365-1367.
10. Bendall J.K., Damy T., Ratajczak P., Loyer X., Monceau V., Marty I., et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 2004, 110:2368-2375.
11. Damy T., Ratajczak P., Robidel E., Bendall J.K., Oliviéro P., Boczkowski J., et al. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 2003, 17:1934-1936.
12. Dawson D., Lygate C.A., Zhang M.H., Hulbert K., Neubauer S., Casadei B., et al. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 2005, 112:3729-3737.
13. Burkard N., Williams T., Czolbe M., Blömer N., Panther F., Link M., et al. Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion. Circulation 2010, 122:1588-1603.
14. Zhang Y.H., Dingle L., Hall R., Casadei B. The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium. Biochim Biophys Acta 2009, 1787:811-817.
15. Kinugawa S., Huang H., Wang Z., Kaminski P.M., Wolin M.S., Hintze T.H. A defect of neuronal nitric oxide synthase increases xanthine oxidase derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ Res 2005, 96:355-362.
16. Moreno C., López A., Llinás M.T., Rodríguez F., López-Farré A., Nava E., et al. Changes in NOS activity and protein expression during acute and prolonged ANG II administration. Am J Physiol Regul Integr Comp Physiol 2002, 282:R31-R37.
17. Tambascia R.C., Fonseca P.M., Corat P.D., Moreno H., Saad M.J., Franchini K.G. Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats. Hypertension 2001, 37:1423-1428.
18. Castro-Chaves P., Fontes-Carvalho R., Pintalhao M., Pimentel-Nunes P., Leite-Moreira A.F. Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart. Exp Physiol 2009, 94:665-674.
19. Ferreira-Martins J., Leite-Moreira A.F. Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle. J Biomed Biotechnol 2010, 2010:807084.
20. Furfine E.S., Carbine K., Bunker S., Tanoury G., Harmon M., Laubach V., et al. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-l-thiocitrulline and S-ethyl-l-thiocitrulline. J Biol Chem 1994, 28(269 (43)):26677-26683.
21. Jones E.S., Vinh A., McCarthy C.A., Gaspari T.A., Widdop R.E. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008, 120(3):292-316.
22. Cai H., Li Z., Dikalov S., Holland S.M., Hwang J., Jo H., et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002, 277(50):48311-48317.
23. Fernhoff N.B., Derbyshire E.R., Marletta M.A. A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase. Proc Natl Acad Sci USA 2009, 106(51):21602-21607.
24. Wang L., Li D., Dawson T.A., Paterson D.J. Long-term effect of neuronal nitric oxide synthase over-expression on cardiac neurotransmission mediated by a lentiviral vector. J Physiol 2009, 587:3629-3637.
25. Burkard N., Rokita A.G., Kaufmann S.G., Hallhuber M., Wu R., Hu K., et al. Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 2007, 100(3):e32-e44.
26. Mohamed T.M., Oceandy D., Prehar S., Alatwi N., Hegab Z., Baudoin F.M., et al. Specific role of neuronal nitric-oxide synthase when tethered to the plasma membrane calcium pump in regulating the beta-adrenergic signal in the myocardium. J Biol Chem 2009, 284(18):12091-12098.
27. Khairallah M., Khairallah R.J., Young M.E., Allen B.G., Gillis M.A., Danialou G., et al. Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency. Proc Natl Acad Sci USA 2008, 105(19):7028-7033.
28. Tsai E.J., Liu Y., Koitabashi N., Bedja D., Danner T., Jasmin J.F., et al. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylate cyclase in the heart modulates enzyme stimulation. Circ Res 2012, 110(2):295-303.
29. Wang H., Kohr M.J., Traynham C.J., Wheeler D.G., Janssen P.M., Ziolo M.T. Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. Am J Physiol Cell Physiol 2008, 294:C1566-C1575.
30. Frantz S., Klaiber M., Baba H.A., Oberwinkler H., Völker K., Gaβner B., et al. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I. Eur Heart J Dec 23 2011, [Electronic publication ahead of print].
31. Haworth R.S., Cuello F., Avkiran M. Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation. Basic Res Cardiol 2011, 106(1):51-63.
32. MacDonnell S.M., Kubo H., Harris D.M., Chen X., Berretta R., Barbe M.F., et al. Calcineurin inhibition normalizes beta-adrenergic responsiveness in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2007, 293(5):H3122-H3129.
33. 2+ release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res 2009, 104(4):514-521.
34. Kobayashi M., Furukawa Y., Chiba S. Positive chronotropic and inotropic effects of angiotensin II in the dog heart. Eur J Pharmacol 1978, 50:17-25.
35. Moravec C.S., Schluchter M.D., Paranandi L., Czerska B., Stewart R.W., Rosenkranz E., et al. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation 1990, 82:1973-1984.
36. Ishihata A., Endoh M. Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis. Br J Pharmacol 1995, 114:447-453.
37. Marano G., Formigari R., Vergari A. Effects of angiotensin II on myocardial contractility during short-term pressor responses to angiotensin II. J Hypertens 1997, 15:1019-1025.
38. Palomeque J., Sapia L., Hajjar R.J., Mattiazzi A., Petroff M. Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. Am J Physiol Heart Circ Physiol 2006, 290:H96-H106.
39. Sekine T., Kusano H., Nishimaru K., Tanaka Y., Tanaka H., Shigenobu K. Developmental conversion of inotropism by endothelin I and angiotensin II from positive to negative in mice. Eur J Pharmacol 1999, 374:411-415.
40. Gusev K., Domenighetti A.A., Delbridge L.M., Pedrazzini T., Niggli E., Egger M. Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling. Circ Res 2009, 105(1):42-50.
41. Teekakirikul P., Eminaga S., Toka O., Alcalai R., Wang L., Wakimoto H., et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest 2010, 120:3520-3529.
42. Wenzel S., Henning K., Habbig A., Forst S., Schreckenberg R., Heger J., et al. TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes. Basic Res Cardiol 2010, 105:621-629.